Cyclacel pharmaceuticals inc

316 views

Published on

The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
316
On SlideShare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
6
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Cyclacel pharmaceuticals inc

  1. 1. Cyclacel Pharmaceuticals Inc. – Product Pipeline Review – Q2 2011Report SummaryGlobal Market Direct’s pharmaceuticals report, “Cyclacel Pharmaceuticals Inc. - ProductPipeline Review - Q2 2011” provides data on the Cyclacel Pharmaceuticals Inc.’s researchand development focus. The report includes information on current developmental pipeline,complete with latest updates, and features on discontinued and dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Cyclacel Pharmaceuticals Inc.’s corporate website, SEC filings,investor presentations and featured press releases, both from Cyclacel Pharmaceuticals Inc.and industry-specific third party sources, put together by Global Markets Direct’s team.Scope• Cyclacel Pharmaceuticals Inc. - Brief Cyclacel Pharmaceuticals Inc. overview includingbusiness description, key information and facts, and its locations and subsidiaries.• Review of current pipeline of Cyclacel Pharmaceuticals Inc. human therapeutic division.• Overview of pipeline therapeutics across various therapy areas.• Coverage of current pipeline molecules in various stages of drug development, includingthe combination treatment modalities, across the globe.• Product profiles for late stage and clinical stage products of Cyclacel Pharmaceuticals Inc.with complete description of the product’s developmental history, mechanism of action,therapeutic class, target and major milestones.• Recent updates of the Cyclacel Pharmaceuticals Inc.’s market pipeline in the last quarter.• Key discontinued and dormant projects.• Latest news and deals relating to the products.Browse All Pharmaceuticals Market Research ReportsReasons to buy• Evaluate Cyclacel Pharmaceuticals Inc.’s strategic position with total access to detailedinformation on its product pipeline.• Assess the growth potential of Cyclacel Pharmaceuticals Inc. in its therapy areas of focus.• Identify new drug targets and therapeutic classes in the Cyclacel Pharmaceuticals Inc.’sR&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.• Exploit in-licensing opportunities by identifying windows of opportunity to fill portfoliogaps.• Exploit collaboration and partnership opportunities with Cyclacel Pharmaceuticals Inc..• Avoid Intellectual Property Rights related issues.• Explore the dormant and discontinued projects of Cyclacel Pharmaceuticals Inc. andidentify potential opportunities in those areas. Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Cyclacel Pharmaceuticals Inc. Snapshot 5
  2. 2. Cyclacel Pharmaceuticals Inc. Overview 5Key Information 5Key Facts 5Cyclacel Pharmaceuticals Inc. – Research and Development Overview 6Key Therapeutic Areas 6Cyclacel Pharmaceuticals Inc. – Pipeline Review 9Pipeline Products by Stage of Development 9Pipeline Products – Monotherapy 10Pipeline Products – Combination Treatment Modalities 11Cyclacel Pharmaceuticals Inc. – Pipeline Products Glance 12Cyclacel Pharmaceuticals Inc. – Late Stage Pipeline 12Phase III Products/Combination Treatment Modalities 12Cyclacel Pharmaceuticals Inc. Clinical Stage Pipeline Products 13Phase II Products/Combination Treatment Modalities 13Phase I Products/Combination Treatment Modalities 14Cyclacel Pharmaceuticals Inc.–Early Stage Pipeline Products 15Pre-Clinical Products/Combination Treatment Modalities 15Discovery Products/Combination Treatment Modalities 16Cyclacel Pharmaceuticals Inc. – Drug Profiles 17Sapacitabine 17Product Description 17Mechanism of Action 17R&D Progress 17Sapacitabine + Decitabine 19Product Description 19Mechanism of Action 19R&D Progress 19Sapacitabine 20Product Description 20Mechanism of Action 20R&D Progress 20Seliciclib 22Product Description 22Mechanism of Action 22R&D Progress 22Cell Cycle Inhibitors Program 23Product Description 23Mechanism of Action 23R&D Progress 23CYC116 24Product Description 24Mechanism of Action 24R&D Progress 24Sapacitabine + Seliciclib 25Product Description 25Mechanism of Action 25R&D Progress 25CDK Inhibitors Program 26Product Description 26Mechanism of Action 26R&D Progress 26
  3. 3. CYC065 27Product Description 27Mechanism of Action 27R&D Progress 27GSK-3 Inhibitors Program 28Product Description 28Mechanism of Action 28R&D Progress 28PLK1 Inhibitor Program 29Product Description 29Mechanism of Action 29R&D Progress 29GSK-3 Inhibitors Program 30Product Description 30Mechanism of Action 30R&D Progress 30Cyclacel Pharmaceuticals Inc. – Pipeline Analysis 31Cyclacel Pharmaceuticals Inc. – Pipeline Products by Therapeutic Class 31Cyclacel Pharmaceuticals Inc. - Pipeline Products By Target 33Cyclacel Pharmaceuticals Inc. – Pipeline Products by Route of Administration 34Cyclacel Pharmaceuticals Inc. – Pipeline Products by Molecule Type 35Cyclacel Pharmaceuticals Inc. – Recent Pipeline Updates 36Cyclacel Pharmaceuticals Inc. - Dormant Projects 39Cyclacel Pharmaceuticals Inc. - Discontinued Pipeline Products 40Discontinued Pipeline Product Profiles 40Cell Cycle Inhibitors Program 40Cyclin Binding Groove Inhibitors 41Hdm2 Inhibitor Program 41Cyclacel Pharmaceuticals Inc. – Locations And Subsidiaries 42Head Office 42Other Locations & Subsidiaries 42Appendix 43Methodology 43Coverage 43Secondary Research 43Primary Research 43Expert Panel Validation 44Contact Us 44Disclaimer 44List of TablesCyclacel Pharmaceuticals Inc. - Pipeline by Therapy Area and Indication, 2011Cyclacel Pharmaceuticals Inc. - Pipeline by Stage of Development, 2011Cyclacel Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2011Cyclacel Pharmaceuticals Inc. - Combination Treatment Modalities in Pipeline, 2011Cyclacel Pharmaceuticals Inc. - Phase III, 2011Cyclacel Pharmaceuticals Inc. - Phase II, 2011Cyclacel Pharmaceuticals Inc. - Phase I, 2011Cyclacel Pharmaceuticals Inc. - Pipeline By Therapeutic Class, 2011Cyclacel Pharmaceuticals Inc. - Pipeline By Target, 2011Cyclacel Pharmaceuticals Inc. - Pipeline By Route of Administration, 2011Cyclacel Pharmaceuticals Inc. - Pipeline By Molecule Type, 2011
  4. 4. Cyclacel Pharmaceuticals Inc. - Recent Pipeline Updates, 2011 Cyclacel Pharmaceuticals Inc. - Dormant Developmental Projects, 2010 Cyclacel Pharmaceuticals Inc. - Discontinued Pipeline Products, 2010 Cyclacel Pharmaceuticals Inc., Other Locations Cyclacel Pharmaceuticals Inc., Subsidiaries List of Figures Cyclacel Pharmaceuticals Inc. - Pipeline by Therapy Area and Indication, 2011 Cyclacel Pharmaceuticals Inc. - Pipeline by Stage of Development, 2011 Cyclacel Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2011 Cyclacel Pharmaceuticals Inc. - Combination Treatment Modalities in Pipeline, 2011 Cyclacel Pharmaceuticals Inc. - Pipeline By Therapeutic Class, 2011 Cyclacel Pharmaceuticals Inc. - Pipeline By Target, 2011 Cyclacel Pharmaceuticals Inc. - Pipeline By Molecule Type, 2011About Us:ReportsnReports is an online library of over 100,000+ market research reports and in-depthmarket research studies & analysis of over 5000 micro markets. We provide 24/7 online andoffline support to our customers. Get in touch with us for your needs of market researchreports.Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Pagehttp://www.facebook.com/pages/ReportsnReports/191441427571689Contact:Mr.Priyank7557 Rambler road,Suite727,Dallas,TX75231Tel: +1-888-989-8004E-mail: sales@reportsnreports.comhttp://www.reportsnreports.comVisit our Market Research Blog

×